Clinical and Experimental Hepatology
eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
Share:
Send email
Share:
Original paper

Campesterol induces apoptosis and inhibits proliferation in HepG2 liver cancer cells

Awais Altaf
1
,
Tahir Maqbool
1
,
Amber Hassan
2
,
Gul E. Nasreen
3
,
Mah G. Summan
4
,
Aisha Tahir
5
,
Urooj Iqbal
6
,
Dahlia S. Mirdad
7
,
Ebtihal Alharbi
8
,
Hussain Noorwali
9
,
Ali A. Mousa
10
,
Zayd Jastaniah
11
,
Nazia Koser
12

  1. Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan
  2. European School of Molecular Medicine (SEMM), University of Milan, Italy
  3. Abwa Medical College, Faisalabad, Pakistan
  4. WMO ENT Department, Lahore General Hospital, Lahore, Pakistan
  5. Department of Biochemistry, University of Health Sciences Lahore, Pakistan
  6. Specialized Healthcare and Medical Education Department Lahore Punjab, Pakistan
  7. Department of Basic Medical Sciences, Faculty of Medicine, University of Jeddah, Jeddah, Saudi Arabia
  8. Department of Pathology, Faculty of Medicine, King Abdulaziz University, Rabigh, Saudi Arabia
  9. Department of Basic Medical Sciences, Division of Pathology, Faculty of Medicine, University of Jeddah, Jeddah, Saudi Arabia
  10. Department of Anatomy, Collage of Medicine, Jouf University, Sakaka, Jouf, Saudi Arabia
  11. Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University, Rabigh, Saudi Arabia
  12. Department of Pharmacy, The University of Lahore, Pakistan
Clin Exp HEPATOL 2026; 12, 1
DOI: https://doi.org/10.5114/ceh.2025.158317
Online publish date: 2026/01/22
Article file
- Campesterol.pdf  [0.10 MB]
Get citation
 
PlumX metrics:
 
1. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74: 229-263.
2. Starnawski P, Nowak K, Augustyn Z, et al. Role of hepatotropic viruses in promoting hepatocellular carcinoma – current knowledge and recent advances. Med Oncol 2025; 42: 111.
3. Sabir K, Sajid J, Butt NI, et al. Clinical profile and outcome of patients with advanced hepatocellular carcinoma [HCC] taking sorafenib or lenvatinib: Real-world experience from a low-middle resource country. Cureus 2025; 17: e83681.
4. Ioannou GN. Epidemiology and risk-stratification of NAFLD-associated HCC. J Hepatol 2021; 75: 1476-1484.
5. Yip TCF, Lee HW, Chan WK, et al. Asian perspective on NAFLD-associated HCC. J Hepatol 2022; 76: 726-734.
6. Park S, Davis AM, Pillai AA. Prevention, diagnosis, and treatment of hepatocellular carcinoma. JAMA 2024; 332: 1013-1014.
7. Akkol E, Acıkara O. Phytosterols in the treatment of gastrointestinal tract cancers. in: phytonutrients in the treatment of gastrointestinal cancer [Internet]. Bentham Science Publishers 2023 (cited 2025 Aug 11); 231-262. Available from: https://www.benthamdirect.com/content/books/9789815049633.chap10
8. Maqbool T, Awan SJ, Malik S, et al. In-vitro anti-proliferative, apoptotic and antioxidative activities of medicinal herb kalonji [Nigella sativa]. Curr Pharm Biotechnol 2019; 20: 1288-1308.
9. Pintor AVB, Queiroz LD, Barcelos R, et al. MTT versus other cell viability assays to evaluate the biocompatibility of root canal filling materials: a systematic review. Int Endod J 2020; 53: 1348-1373.
10. Banik D, Patra P. Possibility of liver cancer treatment by nanoformulation of phenolic phytochemicals. Curr Nanomedicine 2022; 12: 108-125.
11. Galle PR, Forner A, Llovet JM, et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 2018; 69: 182-236.
12. Kendall T, Verheij J, Gaudio E, et al. Anatomical, histomorphological and molecular classification of cholangiocarcinoma. Liver Int 2019; 39: 7-18.
13. Gaballah HH, Gaber RA, Mohamed DA. Apigenin potentiates the antitumor activity of 5-FU on solid Ehrlich carcinoma: Crosstalk between apoptotic and JNK-mediated autophagic cell death platforms. Toxicol Appl Pharmacol 2017; 316: 27-35.
14. Chen H, Guan Q, Guo H, et al. The genetic changes of hepatoblastoma. Front Oncol 2021; 11: 690641.
15. Mandlik DS, Mandlik SK. Herbal and natural dietary products: Upcoming therapeutic approach for prevention and treatment of hepatocellular carcinoma. Nutr Cancer 2021; 73: 2130-2154.
16. Wu J, Li Y, He Q, Yang X. Exploration of the use of natural compounds in combination with chemotherapy drugs for tumour treatment. Molecules 2023; 28: 1022.
17. Kumar N, Singh H, Sharma SK. Antioxidants: responses and importance in plant defence system. In: Roychowdhury R, Choudhury S, Hasanuzzaman M, Srivastava S (Eds.). Sustainable agriculture in the era of climate change [Internet]. Cham: Springer International Publishing; 2020 (cited 2025 Aug 12); 251-264. Available from: https://doi.org/10.1007/978-3-030-45669-6_11
18. Jampilek J, Kralova K. Anticancer applications of essential oils formulated into lipid-based delivery nanosystems. Pharmaceutics 2022; 14: 2681.
19. Ali SS, Al-Tohamy R, Al-Zahrani M, et al. Essential oils and plant-derived bioactive compounds: a comprehensive review of their therapeutic potential, mechanisms of action, and advances in extraction technologies. Phytochem Rev [Internet] 2025 (cited 2025 Aug 12). Available from: https://doi.org/10.1007/s11101-025-10123-8
20. Bae H, Park S, Yang C, et al. Disruption of endoplasmic reticulum and ROS production in human ovarian cancer by campesterol. Antioxidants 2021; 10: 379.
21. Silva BIM, Nascimento EA, Silva CJ, et al. Anticancer activity of monoterpenes: a systematic review. Mol Biol Rep 2021; 48: 5775-5785.
22. Uttu AJ, Sallau MS, Ibrahim H, Iyun ORA. Isolation, characterisation, and docking studies of campesterol and β-sitosterol from Strychnos innocua [Delile] root bark. J Taibah Univ Med Sci 2023; 18: 566-578.
23. Rajabi S, Maresca M, Yumashev AV, et al. The most competent plant-derived natural products for targeting apoptosis in cancer therapy. Biomolecules 2021; 11: 534.
24. Laka K, Makgoo L, Mbita Z. Cholesterol-lowering phytochemicals: targeting the mevalonate pathway for anticancer interventions. Front Genet 2022; 13: 841639.
25. Barut Z, Aslan M, Çırçırlı B, et al. Antiproliferative effect of 7-ketositosterol in breast and liver cancer cells: possible impact on ceramide, extracellular signal-regulated kinases, and nuclear factor kappa B signalling pathways. Pharmaceuticals 2024; 17: 860.
26. Bae H, Park S, Ham J, et al. ER-mitochondria calcium flux by β-sitosterol promotes cell death in ovarian cancer. Antioxidants 2021; 10: 1583.
Copyright: © Clinical and Experimental Hepatology. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/) enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2026 Termedia Sp. z o.o.
Developed by Bentus.